Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.

Author: CarlomagnoChiara, CinelliMariapia, Di CrescenzoVincenzo, GarziAlfredo, GuerraAnna, TonaccheraMassimo, VitaleMario, ZeppaPio

Paper Details 
Original Abstract of the Article :
Anaplastic thyroid cancer (ATC) is a rare, lethal disease associated with a median survival of 6 months despite the best multidisciplinary care. Surgical resection is not curative in ATC patients, being often a palliative procedure. Multidisciplinary care may include surgery, loco-regional radiother...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851243/

データ提供:米国国立医学図書館(NLM)

Anaplastic Thyroid Cancer: Navigating a Complex Landscape

Anaplastic thyroid cancer (ATC) is a rare and aggressive form of cancer, often presenting as a formidable challenge for healthcare providers. This systematic review examines the prevalence of genetic alterations in ATC and explores the potential of targeted therapies to combat this disease. It's like mapping the terrain of a treacherous desert, identifying key landmarks and strategizing the best routes for survival.

Unveiling Genetic Targets for Therapy

The review highlights the numerous molecular alterations detected in ATC, providing a comprehensive picture of the genetic landscape of this disease. These genetic alterations serve as potential targets for targeted therapies, like finding vulnerable spots in a desert fortress that can be exploited for a successful attack. The study specifically focuses on kinase-targeted inhibitors, a class of drugs that can effectively block the activity of specific proteins involved in cancer cell growth.

Hope on the Horizon for ATC Patients

The review underscores the growing importance of personalized medicine, where treatments are tailored to the specific genetic profile of each patient. It's like understanding the unique challenges of navigating a particular desert region, allowing for better preparation and a higher chance of success. This personalized approach could lead to more effective and targeted treatments for ATC, offering hope for improved outcomes for patients facing this challenging disease.

Dr.Camel's Conclusion

This systematic review sheds light on the complex genetic landscape of anaplastic thyroid cancer, highlighting the potential for targeted therapies to improve treatment outcomes. It's a testament to the ongoing scientific quest to develop effective and personalized treatments for a wide range of cancers, much like tireless desert explorers seeking new paths to conquer challenging environments and unlock hidden treasures.

Date :
  1. Date Completed 2014-08-20
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24267151

DOI: Digital Object Identifier

PMC3851243

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.